Authors on the Web
CEOcast, June 4, 2012
...SNS01-T administered by intravenous infusion in patients with relapsed or refractory multiple myeloma,” will be presented by Dr. John Lust, the principal investigator from the Mayo Clinic, Rochester, Minnesota. Senesco closed at $0.24, up $0.04 for the...
Seeking Alpha, January 18, 2013
...and ischemia. Senesco has reported that interim results from the ongoing Phase 1b/2a study were presented by Dr. John Lust, the PI at Mayo Clinic, Rochester, Minnesota at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition in...
Yahoo! News Australia, January 14, 2013
...Thriller | M John McBurney, a wounded civil war soldier, wakes up in a seminary filled with beautiful women. But the paradise quickly turns dangerous, as John's lust backfires on him....
Newton Citizen, January 10, 2013
...A caution is in order: the red berries are toxic and especially dangerous to young children, according to John Lust in "The Herb Book." American holly has been a traditional decoration at Christmastime and its contrasting green and red have become the...
Rockdale Citizen, January 9, 2013
...A caution is in order: the red berries are toxic and especially dangerous to young children, according to John Lust in "The Herb Book." American holly has been a traditional decoration at Christmastime and its contrasting green and red have become the...
PipelineReview, December 11, 2012
...QB: SNTI) reported today that interim results from the on-going Phase 1b/2a study were presented yesterday by Dr. John Lust, the PI at Mayo Clinic, Rochester, MN at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta,...
Drugs.com, December 11, 2012
...QB: SNTI) reported today that interim results from the on-going Phase 1b/2a study were presented yesterday by Dr. John Lust, the PI at Mayo Clinic, Rochester, MN at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta,...
Pharma Live, December 11, 2012
...QB: SNTI) reported today that interim results from the on-going Phase 1b/2a study were presented yesterday by Dr. John Lust, the PI at Mayo Clinic, Rochester, MN at the 54th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta,...

